市場調查報告書
商品編碼
1261462
2022-2028 年按應用、最終用戶、地區分列的微生物發酵技術展望和預測的全球市場規模、份額、行業趨勢分析報告Global Microbial Fermentation Technology Market Size, Share & Industry Trends Analysis Report By Application, By End User, By Regional Outlook and Forecast, 2022 - 2028 |
微生物發酵技術市場規模預計到 2028 年將達到 424 億美元,預測期內復合年增長率為 5.4%。
許多技術,例如產品或底物評估、顯微鏡檢查、毒性測試或生物量監測,提供了菌株性狀和要求的全面信息,從而可以控制特定的發酵過程。幫助您 酵母是單細胞微生物,產生乙醇和二氧化碳參與紙漿發酵,同時產生維生素、氨基酸和其他代謝物幫助細菌生長。
它還具有必需的芳香成分以及蛋白水解和脂解活性。 酵母發酵過程包括啤酒、葡萄酒、蘋果酒發酵等酒精發酵和咖啡、麵包、巧克力發酵等非酒精酵母發酵。 酵母是自然界中普遍存在的單細胞真核微生物。 一種稱為真菌的生物體,其中還包括蘑菇和黴菌。
COVID-19 影響分析
全球市場已轉向微生物菌株生產技術,以增加微生物藥物的產量。 此外,政府支持大中小型生物科技公司研究改善腸道環境和增強免疫力的疫苗、藥物和產品。 因此,大流行有助於加快與該技術相關的研發過程。 然而,行業停工和供應鏈中斷阻礙了技術在其他領域的使用。 因此,大流行對微生物發酵技術市場產生了一定影響。
市場增長因素
對酒精飲料的需求不斷增長
酒店、餐廳、酒館和酒吧對酒精飲料的需求正在增加。 每年,全球消耗約 4460 億升葡萄酒、烈酒和啤酒。 啤酒、貯藏啤酒和蘋果酒約佔酒精消費總量的 4000 億升,葡萄酒和烈酒分別位居第二和第三位。 隨著許多發展中國家對手工烈酒的需求增加,預計酒精飲料行業也會增長。 因此,對酒精飲料的需求增加預計將推動對微生物發酵技術的需求,從而確保市場增長。
食品強化技術的應用取得進展
用平菇進行固態發酵可提高機械控制雙低菜粕的蛋白質含□□量,並將芥子油甘和植酸鹽含量分別降低高達 98.8% 和 75.8%。 此外,在豆粕 (SBM) 中,固態發酵增加了氨基酸和蛋白質含量,對枯草芽孢桿菌的影響大於對米曲霉的影響。 這些已建立的實驗結果擴展了微生物發酵技術的使用案例。 因此,由於這些因素,微生物發酵技術市場有望在未來幾年擴大。
市場製約因素
發酵過程問題
由於持續的自然變化,發酵食品會隨著時間的推移而受到污染。 但是,即使沒有波動,也很容易被污染源污染。 另外,雜質較多,需要多加工。 結果,有害細菌繁殖,有益微生物滅絕,無意間令人不快。 固態發酵等常見發酵工藝也有缺點,例如使用只能耐受低水分含量的微生物以及無法準確監測 SSF。 因此,與微生物發酵過程相關的這些困難可能會阻礙未來幾年的市場增長。
應用展望
根據應用,微生物發酵技術市場分為抗生素、益生菌補充劑、單克隆抗體、重組蛋白、生物仿製藥、疫苗、□、小分子等。 2021年微生物發酵技術市場中,單克隆抗體領域正迎來大幅增長。 單克隆抗體是用於各種應用的最有用的生物製品之一。 這些化合物的高結合親和力、選擇性和特異性通常是有利的。
最終用戶視角
按最終用戶劃分,微生物發酵技術市場分為生物製藥公司、合同研究組織 (CRO)、CMO 和 CDMO 以及學術和研究機構。 2021 年,合同製造組織 (CRO) 和合同開發與製造組織 (CDMO) 細分市場在微生物發酵技術市場的收入份額最大。 CMO 和 CDMO 是生物治療藥物生產商的首選,因為生物加工行業的大部分發明是由中小型企業生產的,這些企業不具備開發這些產品所需的能力、熟練的人力和資源。正在迅速發展進入
區域展望
按地區劃分,對北美、歐洲、亞太地區和拉美地區的微生物發酵技術市場進行了分析。 亞太地區將在 2021 年獲得微生物發酵技術市場最大的收入份額 這是因為亞洲國家被公認為生物製藥行業的外包中心。 據估計,全球 50% 的新生物加工設施由亞洲公司建造,其中包括國內競爭對手和國際巨頭。 例如,中國計劃建設多個生物加工設施以滿足國內需求。
The Global Microbial Fermentation Technology Market size is expected to reach $42.4 billion by 2028, rising at a market growth of 5.4% CAGR during the forecast period.
Microbial fermentation technology is novel, promising, and increasing quickly. This field uses microbes to produce substances with enormous applications in manufacturing biofuels, pharmaceuticals, environmentally friendly materials, fine chemicals, energy, and the food sector. For decades, this technology has been employed in producing highly prized goods. Still, to accomplish the shift to a bio-based society, it is urgently necessary to dramatically speed this technology's development.
Also, there is constant interest in and demand for developing novel microbial fermentation methods for several crucial reasons, including the potential to produce novel compounds and the sustainability element. One of the most crucial elements of contemporary biotechnology is fermentation engineering, which has been widely used in many fields.
Many techniques, like product and substrate evaluation, microscopy, toxicity tests, or biomass monitoring, help to provide a comprehensive image of the traits and requirements of the strains and allow control over specific fermentation processes. Yeasts are single-cell microorganisms that participate in pulque fermentation by producing ethanol and carbon dioxide while also assisting bacterial growth by creating vitamins, amino acids, and other metabolites.
They also provide the necessary aromatic constituents and proteolytic and lipolytic activities. The processes used to ferment yeast include alcoholic fermentations like beer, wine, and cider fermentation, as well as non-alcoholic yeast fermentations like coffee, bread, and chocolate fermentation. Yeasts are unicellular, eukaryotic microfungi found all over the natural world. They are part of the class of organisms known as fungi, which also include mushrooms and molds.
COVID-19 Impact Analysis
Markets worldwide started focusing on microbial strain production technology as it increased the output of microbial-based medications. Additionally, the government supports both small and large biotechnology companies in researching vaccinations, medicines, and products that improve gut health and boost immunity. Therefore, the pandemic aided in speeding up the R&D processes associated with the technology. But the closure of industries and disruptions of supply chains prevented the use of technology in any other sector. As a result, the pandemic had a moderate impact on the microbial fermentation technology market.
Market Growth Factors
Increasing demand for alcoholic beverages
Demand for alcoholic beverages has increased in establishments like hotels, restaurants, taverns, and pubs. Every year, wine, spirits, and beer are consumed worldwide in amounts of about 446 billion liters. Beer, lagers, and cider account for about 400 billion liters of all alcohol consumed, with wine and spirits coming in second and third, respectively. Additionally, the industry for alcoholic beverages is predicted to rise due to the growing demand for artisanal spirits in many developing nations. Therefore, as the demand for alcoholic beverages rises, it will propel the demand for microbial fermentation technology, which will ensure the market's growth.
Rising utilization of technology in food enrichment
The amount of protein in mechanically controlled canola meal increased after solid-state fermentation using Pleurotus ostreatus, and the amounts of glucosinolates and phytate decreased by up to 98.8% and 75.8%, respectively. In soybean meal (SBM), solid-state fermentation boosted the amino acid and protein content, with B. subtilis having a bigger influence than A. oryzae. These established experimental results have expanded the use cases for microbial fermentation technology. Hence, the microbial fermentation technology market will expand in the coming years owing to all these factors.
Market Restraining Factors
Issues associated with the fermentation process
Fermented products can be contaminated over time as they undergo continual natural variations. However, contamination through contamination sources is easy even if no variation occurs. Additionally, the product needs more processing because it is impure. The result was unintended and unpleasant; bad germs grew and multiplied while beneficial microbes perished. Some common fermentation processes, like solid state fermentation, have some drawbacks, including using microorganisms that can only withstand low moisture levels and the inability to precisely monitor SSF. Therefore, such difficulties associated with the microbial fermentation processes may hamper the market's growth in the coming years.
Application Outlook
Based on application, the microbial fermentation technology market is categorized into antibiotics, probiotics supplements, monoclonal antibodies, recombinant proteins, biosimilars, vaccines, enzymes, small molecules, and others. The monoclonal antibodies segment procured a considerable growth rate in the microbial fermentation technology market in 2021. One of the most useful biologics for various applications is monoclonal antibodies. These compounds' high binding affinity, selectivity, and specificity often make them advantageous.
End User Outlook
On the basis of end-user, the microbial fermentation technology market is divided into bio-pharmaceutical companies, contract research organizations (CROs), CMOs & CDMOs, and academic & research institutes. The contract manufacturing organizations (CROs) and contract development & manufacturing organization (CDMOs) segment witnessed the largest revenue share in the microbial fermentation technology market in 2021. CMOs and CDMOs are quickly evolving into the preferred choice for biotherapeutics producers because the majority of the invention in the bioprocess industry is produced by smaller businesses that lack the capacity, skilled personnel, and resources necessary for the development of these products.
Regional Outlook
Region wise, the microbial fermentation technology market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment procured the maximum revenue share in the microbial fermentation technology market in 2021. This results from acknowledging Asian nations as a center for outsourcing in the biopharmaceutical industry. An estimated 50% of new bioprocessing facilities worldwide are being built by Asian businesses, including domestic competitors and international powerhouses. For example, China plans to build several bioprocessing facilities to accommodate domestic demand.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Biocon Limited, BioVectra Inc. (H.I.G. Capital, LLC), Danone S.A., F. Hoffmann-La Roche Ltd., Koninklijke DSM N.V., Lonza Group AG, Novozymes A/S (Novo Holdings A/S), Corbion N.V., and Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN).
Strategies Deployed in Microbial Fermentation Technology Market
Feb-2023: Danone opened a new Research and Innovation Center in Paris. The new research center would enable the company to develop and innovate fresh dairy and plant-based products and 'natural mineral water' categories.
Nov-2022: Biocon took over Viatris, Inc., an American pharmaceutical and healthcare corporation. The acquisition enable the company to emerge as a leading biosimilar player with eight commercialized products. Additionally, it would improve the research and development, global-scale manufacturing, and commercialization abilities of the company.
Nov-2022: BioVectra Inc. unveiled single-use fermentation microbial technology. The new technology contains 100 L and 1,000 L single-use fermenters. The single-use fermentation microbial technology would allow the company to provide greater flexibility, faster turnaround times, and increased capacity utilization to its customers.
Jul-2022: Novozymes introduced Innova Apex and Innova Turbo. The two new advanced yeasts are intended to break down fermentation bottlenecks and at the same time decrease the demand for urea, and also improve ethanol yield. The yeasts maximize the fermentation process, thereby enabling ethanol producers to achieve their production targets. The Innova Apex pushes the plant to 36 & dry solids and decreases glycerol by 38%.
Sep-2021: BioVectra signed an agreement with ABEC, a customized process solutions and services provider. The integration of ABEC CSR single-use fermentation solutions would enhance BIOVECTRA's high-growth microbial fermentation processes and would enable the company to offer a turnaround product to product and between batches.
Apr-2019: BioVectra Inc. expanded its geographical footprints in Windsor, Canada. The new manufacturing facility enables the company to manufacture substances to be used in developing treatments for cancer, autoimmune diseases, and diabetes.
Mar-2019: DSM and Cargill, agricultural, financial, and industrial products provider, together launches Avansya, a producer of produce zero-calorie, great-tasting sweeteners through fermentation. Avansya would produce sweet-tasting molecules, such as steviol glycosides Reb M and Reb D through a fermentation process.
Market Segments covered in the Report:
By Application
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures